Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Treasury Shares (2016 - 2024)

Historic Treasury Shares for Surgery Partners (SGRY) over the last 11 years, with Q4 2024 value amounting to $886834.0.

  • Surgery Partners' Treasury Shares rose 2134.28% to $886834.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $886834.0, marking a year-over-year increase of 2134.28%. This contributed to the annual value of $886834.0 for FY2024, which is 2134.28% up from last year.
  • As of Q4 2024, Surgery Partners' Treasury Shares stood at $886834.0, which was up 2134.28% from $730850.0 recorded in Q4 2023.
  • In the past 5 years, Surgery Partners' Treasury Shares ranged from a high of $1.7 million in Q4 2021 and a low of $730850.0 during Q4 2023
  • Over the past 5 years, Surgery Partners' median Treasury Shares value was $995413.0 (recorded in 2022), while the average stood at $1.1 million.
  • Per our database at Business Quant, Surgery Partners' Treasury Shares surged by 8654.38% in 2020 and then tumbled by 3986.86% in 2022.
  • Quarter analysis of 5 years shows Surgery Partners' Treasury Shares stood at $1.4 million in 2020, then grew by 14.37% to $1.7 million in 2021, then tumbled by 39.87% to $995413.0 in 2022, then dropped by 26.58% to $730850.0 in 2023, then increased by 21.34% to $886834.0 in 2024.
  • Its Treasury Shares was $886834.0 in Q4 2024, compared to $730850.0 in Q4 2023 and $995413.0 in Q4 2022.